Insurance capital
NAIC designations and regulatory framework
status: draft
NAIC designations and regulatory framework
The NAIC designation determines how much capital an insurance company must hold against an investment. This directly impacts the economics of the trade and, ultimately, whether your deal is viable for insurance capital.
The designation scale
| NAIC Designation | Equivalent Rating | RBC Charge (Life) |
|---|---|---|
| NAIC-1 | AAA to A- | 0.4% |
| NAIC-2 | BBB+ to BBB- | 1.3% |
| NAIC-3 | BB+ to BB- | 4.6% |
| NAIC-4 | B+ to B- | 10.0% |
| NAIC-5 | CCC | 23.0% |
| NAIC-6 | D | 30.0% |
The jump from NAIC-1 to NAIC-2 is significant: 0.4% vs. 1.3% capital charge. That’s more than 3x the capital requirement, which directly impacts the spread an insurer needs to hit their return target.
How designations are determined
For most rated securities, the NAIC designation follows the rating: a AA-rated security gets NAIC-1, a BBB-rated security gets NAIC-2. The Securities Valuation Office (SVO) assigns designations based on the lowest rating if there are multiple ratings.
For certain asset classes (CLO tranches, RMBS), the SVO conducts independent analysis using NAIC-prescribed modeling rather than relying solely on agency ratings. This “modeled” approach can result in different designations than the rating would suggest.
Automatic designation vs. SVO review
Most standard ABS receives automatic designation based on agency ratings:
- Auto ABS with S&P AAA rating: automatic NAIC-1
- Consumer loan ABS with Moody’s Baa2 rating: automatic NAIC-2
- Equipment lease ABS with dual A ratings: automatic NAIC-1
SVO review is required for:
- Unrated securities
- Complex or novel structures
- Certain CLO and RMBS tranches subject to modeling
- Securities with structural features that deviate from standard templates
- Private placements without recognized agency ratings
Filing requirements
Insurance companies report their investments on Schedule D of their annual statement. New purchases need to be properly designated before they show up on the books. For most securities, this is straightforward. For complex structures, you may need SVO pre-clearance.
Timeline for SVO review
| Scenario | Timeline | Action Required |
|---|---|---|
| Automatic designation | Immediate | None - designation follows rating |
| Standard SVO filing | 2-4 weeks | File application with documentation |
| Complex structure review | 4-6 weeks | Pre-filing consultation recommended |
| Novel asset class | 6-8 weeks | May require multiple rounds of analysis |
Timeline tip: If your deal requires SVO review rather than automatic designation, build in 4-6 weeks for the filing process. Get confirmation before closing that the designation will be what the insurer expects.
Schedule D vs. Schedule BA classification
Understanding which schedule your security lands on matters because it affects how insurers view and value the position. Schedule D holds “bonds” with favorable treatment; Schedule BA holds “other invested assets” with different (often less favorable) capital treatment.
Schedule D qualification criteria
For a structured security to qualify for Schedule D treatment, it generally needs:
-
Fixed or determinable payments: Cash flows must be reasonably predictable. Residual tranches and equity interests typically fail this test.
-
No equity characteristics: The security must behave like debt, not equity. This means no participation in residual profits beyond a stated return.
-
Credit enhancement structure: Senior tranches with subordination, overcollateralization, or other structural protections are more likely to qualify.
-
No significant prepayment optionality held by the issuer: Call features at par are generally acceptable, but discretionary early redemption without protection can be problematic.
-
Market-accepted structure: ABS and RMBS with standard features are presumptively Schedule D. Novel structures require SVO review.
What pushes securities to Schedule BA
| Feature | Schedule D Treatment | Schedule BA Treatment |
|---|---|---|
| Residual/equity tranches | Generally no | Yes |
| Preferred equity in an SPV | No | Yes |
| Participation interests with upside | No | Yes |
| Private placements without ratings | May qualify with SVO review | Default if SVO doesn’t approve |
| Unrated senior tranches | Possible with SVO designation | If SVO declines designation |
| Complex/novel structures | Requires SVO pre-clearance | If structure doesn’t fit templates |
Why this matters for your deal
Schedule BA positions:
- Often receive higher capital charges than equivalently-rated Schedule D securities
- May have different valuation treatment (book value vs. fair value)
- Trigger concentration limit considerations separate from Schedule D holdings
- Require separate internal approval processes at some insurers
Practical guidance
If you’re structuring a deal and want insurance capital, confirm Schedule D eligibility early:
- For standard ABS structures (auto, consumer, equipment), Schedule D is presumptive
- For private credit, rated note feeders, or bespoke structures, get SVO guidance before marketing
- For unrated positions, understand that Schedule BA treatment may limit the investor base
- Work with your insurance counsel to review structure against SVO guidelines
Note: Some insurers have internal limits on Schedule BA holdings (e.g., no more than 5% of general account). If your security will be Schedule BA, your addressable market shrinks. Consider structural modifications to achieve Schedule D treatment.
RBC capital charges and pricing implications
The risk-based capital (RBC) charge determines how much capital an insurer must allocate against a position. This directly affects required spreads.
The math
An insurance company with a 12% ROE target needs to earn that return on allocated capital.
NAIC-1 position (0.4% capital charge):
- $100M investment
- $400K capital allocated
- Need $48K return on capital (12% of $400K)
- Required spread: approximately 5 bps just to cover capital cost
NAIC-2 position (1.3% capital charge):
- $100M investment
- $1.3M capital allocated
- Need $156K return on capital
- Required spread: approximately 16 bps just to cover capital cost
This is a simplified view (actual RBC calculations are more complex), but the directional point stands: lower-rated tranches require meaningfully wider spreads to deliver the same return on capital.
The NAIC-1/NAIC-2 cliff effect
The boundary between NAIC-1 and NAIC-2 (A- vs. BBB+) creates a pricing cliff:
| Scenario | Capital Charge | Spread Impact |
|---|---|---|
| A- rated (NAIC-1) | 0.4% | Baseline |
| BBB+ rated (NAIC-2) | 1.3% | +10-15 bps |
If you’re deciding between structuring a single-A tranche vs. a BBB tranche, the pricing differential may be larger than the rating differential suggests because of this boundary.
Capital optimization strategies
Sophisticated insurance investors consider:
- Rating agency selection: Different agencies may assign different ratings to the same risk
- Tranche sizing: Optimizing subordination levels to hit rating boundaries
- Structural features: Triggers and protections that support higher ratings
- Timing: End-of-year purchases may have different capital implications
Concentration limits
NAIC regulations impose concentration limits that affect how much insurance capital is available for any single issuer or asset class:
| Limit Type | Typical Threshold | Impact |
|---|---|---|
| Single issuer | 1-3% of general account | Caps ticket size for large insurers |
| Single asset class | 10-15% of general account | Limits sector concentration |
| Below-investment-grade | 5-10% of general account | Restricts BB and below exposure |
| Private placements | Often limited separately | May constrain unrated deals |
What this means for originators
If your deal requires a $200M ticket from a single insurer:
- The insurer needs at least $7-20B general account (at 1-3% limit)
- Repeat issuance to the same insurer builds concentration
- Large deals may require multiple insurance investors
Recent regulatory developments
The NAIC framework continues to evolve. Recent and pending changes include:
CLO treatment: The NAIC has moved toward modeled approaches for CLO tranches, which can result in different capital charges than rating-based designations.
Residual interest rules: Increased scrutiny of how residual interests are classified and capitalized.
Private credit growth: Regulators are examining the growth of private credit in insurance portfolios, potentially leading to new guidelines.
Schedule BA scrutiny: Heightened attention to assets classified as Schedule BA and their valuation.
Stay current on NAIC developments through the Securities Valuation Office updates and your insurance counsel.
status: draft
Key takeaways
- The NAIC-1 vs. NAIC-2 boundary (A- vs. BBB+) creates a significant capital charge cliff that affects pricing
- Schedule D eligibility is critical for broad insurance market access; Schedule BA limits your investor base
- Build 4-6 weeks into your timeline if SVO review is required
- Concentration limits cap ticket sizes and may require multiple insurance investors for large deals
- Work with insurance counsel to confirm designation and schedule classification before marketing
status: draft
Related topics
- Insurance capital overview - full guide to accessing insurance capital
- Insurance ALM constraints - duration and asset-liability considerations
- Bermuda insurance capital - alternative regulatory framework